![Robert Hedequist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Hedequist
President at
Kineta Immuno-Oncology LLC
Profile
Robert Hedequist is currently the President & Chief Operating Officer at Kineta Chronic Pain LLC and Kineta Immuno-Oncology LLC.
He previously worked as a Director at Kv1.3 Therapeutics, Inc. and as the President & Chief Operating Officer at Kineta, Inc. (Washington).
Robert Hedequist active positions
| Companies | Position | Start |
|---|---|---|
Kineta Immuno-Oncology LLC
 Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Operates as biotechnology company, which develops disruptive technologies that shift the paradigm in cancer treatment by turning cold tumors hot | President | - |
Former positions of Robert Hedequist
| Companies | Position | End |
|---|---|---|
Kineta Chronic Pain LLC
 Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | President | 2025-03-12 |
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Director/Board Member | - |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | President | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Kineta Chronic Pain LLC
Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Develops drugs that modulate and enhance the human immune system | Health Technology |
Kineta Immuno-Oncology LLC
Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Operates as biotechnology company, which develops disruptive technologies that shift the paradigm in cancer treatment by turning cold tumors hot | Health Technology |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Robert Hedequist
